Johnson & Johnson News and Healthcare Innovation

253.92
5.31
2.13 %
Daily range
Weekly range
  • Artem Shendetskii
  • Yesterday
Cramer highlights Goldman, Wells Fargo and Johnson & Johnson as buys amid market weakness
Investor sentiment remains fragile as bank earnings and pressure on memory stocks weigh on Tuesday trading. Against that backdrop, Jim Cramer argues that selected shares still offer buying ...
  • Dmytro Kharkov
  • Yesterday
Johnson & Johnson stock falls as weak momentum dominates short-term trading
Johnson & Johnson (JNJ) stock is trading at $251.79, down 4.64% for the day. The price currently sits below its key short- and medium-term moving averages while ...
  • Parshwa Turakhiya
  • Yesterday
Johnson & Johnson raises full-year outlook as drug sales offset medical device pressure
Johnson & Johnson posts third-quarter revenue and profit above Wall Street estimates as strong demand for autoimmune treatment Tremfya supports its pharmaceutical business. The results also show ...
  • Artem Shendetskii
  • 13.10.2026
Wall Street outlook focuses on bank earnings, Dell appearance and industrial updates
U.S. stocks head into Tuesday with investors watching corporate catalysts after the S&P 500 finished nearly flat Monday amid higher oil prices and weakness in memory chip shares. The next session ...
  • Yaroslav Dmytrenko
  • 08.10.2026
Johnson & Johnson stock remains below resistance with MACD signaling a sell: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $253, extending their decline this week as the chart now signals oversold conditions and mounting short-term pressure. ...
  • Sergey Shendetskyi
  • 01.10.2026
Johnson & Johnson shares trade within narrow range as market awaits earnings catalyst: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $263 after a decline of just over 3% last week, landing the stock in oversold territory on several momentum signals. ...
  • Hlib Chabaniuk
  • 24.09.2026
Johnson & Johnson stock weekly forecast: Holds top of recent range with potential pause near current levels
Shares of Johnson & Johnson (JNJ) are trading near $274, extending their recovery with an advance of around 1.6% over the past week as upbeat corporate news fueled ...
  • Sergey Shendetskyi
  • 17.09.2026
Johnson & Johnson shares test modest upside with bullish MACD flashing 'Strong Buy': weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $268 after a move of just over 1% higher last week, as competing technical signals keep the bias contained. While ...
  • Ksenia Gerey
  • 14.09.2026
AI stocks face pressure as Wall Street tracks safety push, deal talks and analyst calls
Wall Street is heading into Monday's session with sharp pressure on AI semiconductor and infrastructure shares as investors reassess the pace of artificial intelligence development. The market ...
  • Anastasiia Chabaniuk
  • 10.09.2026
Johnson & Johnson stock trades below 20-day average as technical signals clash: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $267 after falling nearly 3% this week as the decline stretches into oversold territory. The daily chart highlights ...
  • Mikhail Vnuchkov
  • 02.09.2026
Johnson & Johnson shares weekly forecast: Upward momentum persists with strong MACD signals
Shares of Johnson & Johnson (JNJ) are trading near $276, extending their recovery with a gain of almost 3% over the past week as investors remain attracted by the ...
  • Ezequiel Gomes
  • 26.08.2026
Johnson & Johnson shares weekly forecast: Buyers remain in control as resistance at $273.98 approaches
Shares of Johnson & Johnson (JNJ) are trading near $272 as recovery momentum continues into a new week. The advance has been relatively modest, but buyers retain control ...
  • Ciaran Ryan
  • 20.08.2026
Shield Therapeutics lifts H1 revenue 42% as it stays on track for 2026 profitability
Shield Therapeutics reports stronger first-half sales and a sharply narrower loss for the six months ended June 30, 2026, as demand for its iron deficiency treatment ACCRUFeR continues to grow in ...
  • Ciaran Ryan
  • 19.08.2026
Johnson & Johnson shares weekly forecast: Strong earnings help sustain upside as momentum persists
Shares of Johnson & Johnson (JNJ) are trading near $275, climbing nearly 6% over the past week as a recovery setup holds firm. Strong earnings and upbeat corporate ...
  • Ciaran Ryan
  • 18.08.2026
Mirae Asset Global Investments stake boost lifts Johnson & Johnson stock toward resistance
Johnson & Johnson (JNJ) stock is trading at $271.22, up 3.37% on the day. The price stands above its key moving averages, highlighting strong upward momentum in the ...
  • Parshwa Turakhiya
  • 11.08.2026
Johnson & Johnson stock weekly forecast: Momentum contained with MACD bullish and volatility steady
Shares of Johnson & Johnson (JNJ) are trading near $259 as the stock extends its recovery from recent lows but faces the risk of being overbought. Corporate momentum ...
  • Ashutosh Sureka
  • 05.08.2026
Eli Lilly raises 2026 outlook as GLP-1 portfolio drives growth
Eli Lilly is strengthening its position in the obesity and diabetes drug market after reporting another quarter of rapid sales growth and lifting its full-year guidance. The results highlight ...
  • Ashutosh Sureka
  • 04.08.2026
Johnson & Johnson stock holds just above $250.92 support as conflicting signals persist: weekly analysis
Shares of Johnson & Johnson (JNJ) are trading near $253 after slipping roughly 1.5% over the past week, as mixed signals on the daily chart highlight uncertainty about ...
  • Ashutosh Sureka
  • 30.07.2026
Will Johnson & Johnson stock hold support as Firefly Bio acquisition triggers profit warning?
Johnson & Johnson (JNJ) stock is trading at $256.02, down 3.58% for the day and closing near the session’s low. The price sits below its short- and medium-term moving ...
  • Ciaran Ryan
  • 29.07.2026
Johnson & Johnson talc settlement supports shares as healthcare rotation adds momentum
Johnson & Johnson shares climb to fresh record highs after the company reaches a $5.5 billion agreement aimed at resolving long-running ovarian cancer litigation tied to talc products. The ...
  • Ciaran Ryan
  • 27.07.2026
Johnson & Johnson shares weekly forecast: MACD maintains a strong buy outlook
Shares of Johnson & Johnson (JNJ) are trading near $267 after gaining around 1.5% over the past week, as a recovering trend remains intact despite a stretched technical ...